prader willi glp 1 Low dose systemic AAV-exendin-4 gene therapy for Prader-Willi syndrome and dietary obesity Prader- Willi syndrome: An uptodate

Importantly, despite modest heart rate increases, cardiovascular outcomes trials have not demonstrated increased cardiovascular risk

But it shouldnt be the only metric you rely on

Concerning symptoms warranting immediate provider contact include severe chills unresponsive to additional clothing or heating, chills accompanied by fever above 100.4F, persistent chills lasting more than 2 weeks, or thermoregulatory symptoms that worsen over time

& Ha, C

Need a prescription for, say, a yeast infection, a migraine, or asthma

In people with T2D, a phase 1b study did not demonstrate improvement in HbA1c, however there was a placebo-adjusted WL of 8.5% after 12 weeks (Table 3)